International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders

External Event - 15th to 20th Mar 2022

Hybrid Event: Barcelona, Spain

Join the upcoming AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders. The groundbreaking series of Alzheimer’s and Parkinson’s Diseases Conferences attract international medical and scientific professionals worldwide. The Conference is at the forefront of unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s, and other related neurodegenerative diseases. AD/PD™ Conferences uniquely combine distinct neurodegenerative diseases in one setting and examine their similarities and differences; a strong focus is mechanisms of disease, prevention, and therapy.

AD/PD™ 2022? brings a new look and a new chapter in the history of the AD/PD™ series of conferences. By merging together with the AAT-AD/PD™ Advances in Alzheimer’s Therapies Focus Meeting, AD/PD™ is now transformed into an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.

The forthcoming AD/PD™ meeting, in 2022 will take place in the enchanting city of Barcelona, Spain. The continuing success of the AD/PD™ meetings is the result of several key ingredients:

1. A high-quality scientific program covering most recent research, developments, and treatments, with emphasis on overlaps and congruent results among AD, PD, and related neurological disorders.
2. A multidisciplinary mix of participants representing both clinical investigators and basic scientists; as well as both established investigators and young upcoming talents.
3. An International Scientific Advisory Board covering a broad range of expertise in AD, PD, and related neurological disorders.
4. A concerted attempt to provide an ambiance at the Conference that encourages interaction, exchange of ideas, and networking opportunities among all participants.
5. Junior Faculty Awards, intended to encourage attendance by young scientists at the Conference.

The reason for this success is the uniqueness of the AD/PD™ meetings, their academic quality combined with the interactive and collegial environment. We believe that there is no other conference in the world that presents such a high level of science in a condensed manner on one hand, yet on the other hand, provides an enormously comfortable atmosphere in which to enjoy it all. We invite you to join us at the AD/PD™ 2022 International Conference on AD and PD, and we hope to welcome you in the Spring of 2022, in Barcelona.

Cutting-Edge Science

The AD/PD™ conference offers a high quality scientific program covering the most recent research, clinical trials, developments, and treatments in Alzheimer’s and Parkinson’s, with emphasis on overlaps and congruent results among AD. This provides participants with unparalleled and powerful insights into distinct neurodegenerative diseases in one setting to examine their similarities and differences.

Top Speakers in the Field

Science and education are the main forces behind AD/PD™ conferences and participants agree that the quality of the content and the educational value are what set it apart from other events in the field. In the 2019 CME Participant evaluation form 96% state that the event contributed to their professional development, while almost 97% agree that the quality of the speakers was excellent.

AD/PD™ in Numbers

A unique conference that provides world class platform for clinical investigators and basic scientists to present, discuss and trade expertise on a broad range of themes and topics, AD/PD™ has gone from strength to strength attracting over 3,800 participants from 75 countries and over 2,200 abstracts.